Healthcare -
Biotechnology - NASDAQ - US
$ 2.46
-0.806 %
$ 85 M
Market Cap
-2.62
P/E
GNLX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss GNLX - Genelux Corporation
14 K
LAST VALUE
164.58%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR